These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25400425)

  • 1. Experimental study on enhancement of the metastatic potential of portal vein tumor thrombus-originated hepatocellular carcinoma cells using portal vein serum.
    Tang Y; Yu H; Zhang L; Wang K; Guo W; Shi J; Liu S; Wu M; Wang H; Cheng S
    Chin J Cancer Res; 2014 Oct; 26(5):588-95. PubMed ID: 25400425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma].
    Hou YK; Wang Y; Cong WM; Wu MC
    Ai Zheng; 2007 Jun; 26(6):591-5. PubMed ID: 17562263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
    Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
    J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT.
    Nguyen XC; Nguyen DS; Ngo VT; Maurea S
    Asia Ocean J Nucl Med Biol; 2015; 3(1):10-7. PubMed ID: 27408876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma.
    Wang T; Hu HS; Feng YX; Shi J; Li N; Guo WX; Xue J; Xie D; Liu SR; Wu MC; Cheng SQ
    Br J Cancer; 2010 May; 102(11):1618-26. PubMed ID: 20461085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroid-transdifferentiated myeloid cells promote portal vein tumor thrombus in hepatocellular carcinoma.
    Zhu WH; Chen J; Huang RK; Zhang Y; Huang ZX; Pang XQ; Hu B; Yang Y; Li X
    Theranostics; 2023; 13(13):4316-4332. PubMed ID: 37649603
    [No Abstract]   [Full Text] [Related]  

  • 8. An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study.
    Zhang XP; Gao YZ; Chen ZH; Chen MS; Li LQ; Wen TF; Xu L; Wang K; Chai ZT; Guo WX; Shi J; Xie D; Wu MC; Yee Lau W; Cheng SQ
    Hepatology; 2019 May; 69(5):2076-2090. PubMed ID: 30586158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis.
    Chen JS; Wang Q; Chen XL; Huang XH; Liang LJ; Lei J; Huang JQ; Li DM; Cheng ZX
    J Surg Res; 2012 Jun; 175(2):243-50. PubMed ID: 21601221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Met inhibitor upregulates E-cadherin, which is lost in portal vein tumor thrombus of hepatocellular carcinoma.
    Abe S; Inagaki Y; Kokudo T; Miyata A; Nishioka Y; Ichida A; Kaneko J; Akamatsu N; Kawaguchi Y; Hasegawa K
    Hepatol Res; 2024 Oct; ():. PubMed ID: 39367844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of different clinicopathologic variables on serum protein fingerprint in hepatocellular carcinoma patients].
    Huang C; Fan J; Zhou J; Liu YK; Cui JF
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):445-9. PubMed ID: 16772076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome sequencing-based personalized analysis of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Qiu Z; Wang G; Yang G; Wang G; Jiang W; Chen Z; Zhu W; Guo H; Zhang F; Gao F
    J Gastrointest Oncol; 2021 Apr; 12(2):795-805. PubMed ID: 34012667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increased level of Th17 cells in peripheral blood correlates with the development of hepatocellular carcinoma].
    Wang WW; Wang ZM; Liu YY; Qin YH; Shen Q
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):757-61. PubMed ID: 21163066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
    Mähringer-Kunz A; Steinle V; Düber C; Weinmann A; Koch S; Schmidtmann I; Schotten S; Hinrichs JB; Graafen D; Pinto Dos Santos D; Galle PR; Kloeckner R
    Liver Int; 2019 Feb; 39(2):324-331. PubMed ID: 30318826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 16. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
    Fan W; Yuan G; Fan H; Li F; Wu Y; Zhao Y; Yao W; Wang Y; Xue M; Yang J; Li J
    Clin Ther; 2019 Aug; 41(8):1463-1476. PubMed ID: 31303279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report.
    Chen X; Liu L; Pan X
    Oncol Lett; 2015 Jun; 9(6):2495-2498. PubMed ID: 26137096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous laser ablation in the treatment of portal vein tumor thrombus in 93 hepatocellular carcinoma patients].
    Lu ZH; Shen F; Yuan GX; Shi LH; Zong M; Yang JH; Guo J; Wu MC
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):449-52. PubMed ID: 17974281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of hepatocellular carcinoma with portal vein tumor thrombus:assessment based on clinical and computer tomography characteristics.
    Jia L; Kiryu S; Watadani T; Akai H; Yamashita H; Akahane M; Ohtomo K
    Acta Med Okayama; 2012; 66(2):131-41. PubMed ID: 22525471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
    Cheng YQ; Wang K; Zhang XP; Wei XB; Jiang YB; Hu YR; Mao FF; Guo WX; Shi J; Cheng SQ
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1214-1221. PubMed ID: 30402968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.